secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0001093557-24-000024
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 1.02, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DexCom terminates warrants for 10.3M shares with Bank of America
----------------------------------------------------------------

- Termination agreement with BofA on Feb 13, 2024, stops warrants covering 10.3M shares of common stock.
- Company will deliver shares to BofA based on 12-day VWAP averaging starting Feb 13, expected to finish in Q1 2024.
- Warrants were part of 2018 convertible note hedge transactions; JPM warrants remain outstanding.
- Shares issued under Section 4(a)(2) exemption; averaging period includes potential disruption adjustments.
- Agreement incorporates Rule 10b5-1 plan, permitting BofA to hedge during the averaging period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355724000024/0001093557-24-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355724000024/dxcm-20240213.htm
  HTML page:      https://secwatch.observer/filing/0001093557-24-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer